Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Trends in androgen prescribing in the United States, 2001 to 2011.

Literature DB >> 23939517

Trends in androgen prescribing in the United States, 2001 to 2011.

Jacques Baillargeon¹, Randall J Urban, Kenneth J Ottenbacher, Karen S Pierson, James S Goodwin.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：
Androgens

Year: 2013 PMID： 23939517 PMCID： PMC4100547 DOI： 10.1001/jamainternmed.2013.6895

Source DB: PubMed Journal: JAMA Intern Med ISSN： 2168-6106 Impact factor: 21.873

× No keyword cloud information.

6 in total

Review 1. Managing the risks of prostate disease during testosterone replacement therapy in older men: recommendations for a standardized monitoring plan.

Authors: Shalender Bhasin; Atam B Singh; Ricky Phong Mac; Ballentine Carter; Martin I Lee; Glenn R Cunningham
Journal: J Androl Date: 2003 May-Jun

2. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.

Authors: Christina Wang; Glenn Cunningham; Adrian Dobs; Ali Iranmanesh; Alvin M Matsumoto; Peter J Snyder; Thomas Weber; Nancy Berman; Laura Hull; Ronald S Swerdloff
Journal: J Clin Endocrinol Metab Date: 2004-05 Impact factor: 5.958

3. Adverse events associated with testosterone administration.

Authors: Shehzad Basaria; Andrea D Coviello; Thomas G Travison; Thomas W Storer; Wildon R Farwell; Alan M Jette; Richard Eder; Sharon Tennstedt; Jagadish Ulloor; Anqi Zhang; Karen Choong; Kishore M Lakshman; Norman A Mazer; Renee Miciek; Joanne Krasnoff; Ayan Elmi; Philip E Knapp; Brad Brooks; Erica Appleman; Sheetal Aggarwal; Geeta Bhasin; Leif Hede-Brierley; Ashmeet Bhatia; Lauren Collins; Nathan LeBrasseur; Louis D Fiore; Shalender Bhasin
Journal: N Engl J Med Date: 2010-06-30 Impact factor: 91.245

4. Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials.

Authors: Olga M Calof; Atam B Singh; Martin L Lee; Anne M Kenny; Randall J Urban; Joyce L Tenover; Shalender Bhasin
Journal: J Gerontol A Biol Sci Med Sci Date: 2005-11 Impact factor: 6.053

Review 5. Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials.

Authors: Rudy M Haddad; Cassie C Kennedy; Sean M Caples; Michal J Tracz; Enrique R Boloña; Kostandinos Sideras; Maria V Uraga; Patricia J Erwin; Victor M Montori
Journal: Mayo Clin Proc Date: 2007-01 Impact factor: 7.616

6. Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study.

Authors: Upendram Srinivas-Shankar; Stephen A Roberts; Martin J Connolly; Matthew D L O'Connell; Judith E Adams; Jackie A Oldham; Frederick C W Wu
Journal: J Clin Endocrinol Metab Date: 2010-01-08 Impact factor: 5.958

6 in total

112 in total

1. The utility and dynamics of salivary sex hormone measurements in the National Social Life, Health, and Aging Project, Wave 2.

Authors: Michael J Kozloski; L Philip Schumm; Martha K McClintock
Journal: J Gerontol B Psychol Sci Soc Sci Date: 2014-11 Impact factor: 4.077

Trends in androgen prescribing in the United States, 2001 to 2011.

Review 1. Managing the risks of prostate disease during testosterone replacement therapy in older men: recommendations for a standardized monitoring plan.

2. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.

3. Adverse events associated with testosterone administration.

4. Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials.

Review 5. Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials.

6. Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study.

1. The utility and dynamics of salivary sex hormone measurements in the National Social Life, Health, and Aging Project, Wave 2.

Review 2. Adverse effects of testosterone replacement therapy: an update on the evidence and controversy.

Review 3. The evaluation and management of testosterone deficiency: the new frontier in urology and men's health.

4. Screening and monitoring in men prescribed testosterone therapy in the U.S., 2001-2010.

5. An update on male hypogonadism therapy.

6. Changes in testosterone prescribing patterns after FDA warning.

7. Trends and Patterns of Testosterone Therapy among U.S. Male Medicare Beneficiaries, 1999 to 2014.

8. Serum Total Testosterone Concentrations in the US Household Population from the NHANES 2011-2012 Study Population.

9. Exogenous testosterone enhances cortisol and affective responses to social-evaluative stress in dominant men.

Review 10. Alternative treatment modalities for the hypogonadal patient.